Consistent with the in vivo findings, immunohistochemistry (IHC) assays of xenografts generated from DDX24-shRNAs+SFN tumor tissues demonstrated an obvious reduction in Ki67, p-EKT, β-catenin and ZO-1 levels (Figure 5d). Here, MKI67 is linked to neoplasm.